Citi Anticipates FOSUN INTL to Report Loss for Last Year, Lowers Target Price to HKD 5.6
Profit Warning from Subsidiary: Shanghai Yuyuan, a subsidiary of FOSUN INTL, has issued a profit warning, projecting a net loss of RMB4.8 billion for FY25.
Overall Loss Forecast: Citi estimates that FOSUN INTL will incur a net loss of approximately RMB778 million for FY25, considering the profit warning and forecasts for its other businesses.
Short Selling Activity: FOSUN INTL has experienced significant short selling, amounting to $16.87 million, with a short selling ratio of 32.096%.
Rating and Target Price Adjustment: Despite the negative outlook, Citi maintains a Buy rating on FOSUN INTL but has reduced its target price from HKD6.5 to HKD5.6.
Trade with 70% Backtested Accuracy
Analyst Views on 00656
About the author


Profit Warning from Subsidiary: Shanghai Yuyuan, a subsidiary of FOSUN INTL, has issued a profit warning, projecting a net loss of RMB4.8 billion for FY25.
Overall Loss Forecast: Citi estimates that FOSUN INTL will incur a net loss of approximately RMB778 million for FY25, considering the profit warning and forecasts for its other businesses.
Short Selling Activity: FOSUN INTL has experienced significant short selling, amounting to $16.87 million, with a short selling ratio of 32.096%.
Rating and Target Price Adjustment: Despite the negative outlook, Citi maintains a Buy rating on FOSUN INTL but has reduced its target price from HKD6.5 to HKD5.6.

IPO Announcement: GON TECHNOLOGY plans to list in Hong Kong, offering 30 million H-shares, with 10% for public offering and 90% for international placement, aiming to raise approximately HKD1.26 billion.
Offer Price and Subscription Details: The share price ranges from HKD34 to HKD42, with an entry fee of about HKD8,484.71 for one board lot (200 shares). The subscription period runs from January 27 to January 30, with listing expected on February 4.
Net Proceeds Estimation: At a median offer price of HKD38 per share, the net proceeds from the IPO are projected to be around HKD1.0577 billion.
Cornerstone Investors: The IPO includes eight cornerstone investors, such as SLD International and Luminous Horizon, collectively subscribing for shares worth nearly HKD320 million.

- ESG Score Improvement: Fosun International's ESG score has risen to 4.2, surpassing industry and Chinese corporate averages, demonstrating its outstanding performance in governance, environment, and social responsibility, which enhances market confidence in its long-term value creation capabilities.
- Excellent Governance Performance: Fosun achieved a full score of 5.0 in Environmental Supply Chain, Anti-Corruption, and Risk Management, while also scoring 5.0 for the first time in Social Supply Chain and Corporate Governance, highlighting its systematic advantages in sustainable development management.
- Increasing International Recognition: Fosun maintains an MSCI ESG rating of AA and an HSI ESG rating of AA-, and has been included in S&P Global's Sustainability Yearbook 2025, ranking in the top 1% in the China Edition, further enhancing its reputation in global capital markets.
- Commitment to Sustainable Development: Fosun is committed to strengthening sustainable development management while ensuring strong business performance, actively fulfilling corporate social responsibilities, and leveraging its global industrial ecosystem to accelerate the implementation of relevant principles and practices.

Fosun and BYD Partnership: Fosun International and BYD Company have established a global long-term strategic partnership focusing on creating a "Mobility + Vacation" integrated ecosystem leveraging their strengths in green mobility and tourism.
Target Audience and Collaboration: The partnership aims to connect BYD's 15 million car owners with Fosun's 20 million members, fostering deep interconnection through product innovation and ecological interconnection.

Fosun International Participation: Fosun International is participating in the China International Import Expo (CIIE) for the eighth consecutive year, showcasing innovative pharmaceuticals and high-end medical devices at their booth.
Focus on Healthcare Innovation: The company emphasizes its commitment to addressing unmet clinical needs in healthcare, leveraging global industrial advantages to promote cutting-edge technologies in China.
Chairman's Statement: Chairman Guo Guangchang highlighted the CIIE as a platform for China's development and international collaboration, aiming for high-level opening-up and global sharing of public products.
Short Selling Data: Fosun International has reported short selling of $5.45 million with a ratio of 28.397%, while Fosun Pharma has $16.21 million in short selling with a ratio of 16.975%.

IPO Announcement: JOYSON ELEC has announced its IPO details in Hong Kong, planning to offer 155.1 million H-shares, with 10% allocated for the Hong Kong public and 90% for international investors.
Financial Details: The maximum offer price is set at HKD23.6 per share, aiming to raise approximately HKD3.66 billion, with an entry fee for a board lot of 500 shares around HKD11,919.01.





